xl820
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2005 (NCT00129571)
Timeline
Indications
Mechanism of action
- Stem cell growth factor receptorINHIBITOR
KIT inhibitor
Vascular endothelial growth factor receptor inhibitor
Platelet-derived growth factor receptor inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545402 ↗
Also known as
- xl820
- xl820
- xl-820
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00570635 | Phase 2 | Dec 1, 2007 | Exelixis |
| NCT00350831 | Phase 1 | Jul 1, 2006 | Exelixis |
| NCT00129571 | Phase 1 | Aug 1, 2005 | Exelixis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Exelixis | For profit | 3 | 3 | 2 | 2005 |
1 organizations
Page 1 / 1